Runda Medical shareholders approve key resolutions at EGM

Shanghai Runda Medical Technology Co., Ltd. announced the resolutions from its first extraordinary general meeting of shareholders, held on September 12, 2025, at the company's Shanghai headquarters. The meeting saw 585 shareholders and proxies attend, representing 33.7354% of total voting shares. All directors and supervisors were present, with some participating virtually.

Key resolutions approved include the cancellation of the supervisory board and the revision of the company's articles of association, which passed with 98.4349% of votes in favor. Additionally, the proposal to re-engage the accounting firm for the 2025 fiscal year was approved, receiving 99.7510% of the votes.

The meeting confirmed that all procedures complied with company law and relevant regulations. The resolution on the cancellation of the supervisory board was considered a special matter, requiring and receiving approval from over two-thirds of the voting shareholders present. All other resolutions were ordinary matters, approved by more than half of the voting shareholders.